Charting works well with Microsoft and Google but not so much...

Charting works well with Microsoft and Google but not so much for this end of the market, IMO. I'm sure SYC is doing all he can with the news he has. My only quibble is that he dances back and forth a bit too much between development lines as news transpires. I recall he was poo-pooing PTX 100 at some point when Omnicar was taking off and now he's back to lauding its praises. Sometimes the eagerness to leap ahead can be your own worst enemy.

PTX 100 is a re-application of a failed drug tested in the past so there's a natural sense of scepticism but times change. We need bigger drug trials. Either this sh*t saves lives or it doesn't. Let's find out. Too much dancing on the edge here. What is needed to get this progressed? Fear of failure is not an option.